Current approaches to therapy for complications of bone metastases from breast cancer

Por L. G. Zhukova
Publicado em 2014-07-01

Dlitel'noe i bezopasnoe primenenie Avastina pri metastaticheskom kolorektal'nom rake: klinicheskiy opyt primeneniya

Por L G Zhukova
Publicado em 2009-03-01

Postneoadjuvant therapy: a new approach to the treatment of HER2-positive breast cancer (KATHERINE study results)

Por L. G. Zhukova, S. A. Smolin
Publicado em 2019-12-01

The place of CDK4/6 inhibitors in real clinical practice for patients with hormone-positive HER2-negative advanced breast cancer: opinion of Moscow’s oncologists

Por L. G. Zhukova, M. A. Mukhina
Publicado em 2020-06-01

The prospects for cisplatin and nab-paclitaxel combination therapy in patients with pre-treated triple-negative breast cancer. Description of the clinical case.

Por L. G. Zhukova, K. S. Bardovskaya, E. V. Lubennikova, I. R. Suslova
Publicado em 2018-07-01

Assessment of the receptor status in primary breast cancer with synchronous loco regional metastases: prognostic and clinical role?

Por O. O. Gordeeva, L. G. Zhukova, I. V. Kolyadina, I. P. Ganshina
Publicado em 2019-04-01

Ribociclib in 1st line HR+ breast cancer treatment

Por L G Zhukova, I P Ganshina, O O Gordeeva, E V Lubennikova
Publicado em 2018-06-01

Early and late postoperative complications of robot-assisted radical subcutaneous mastectomy with endoprosthesis

Por G. E.  Kvetenadze, E. V. Shivilov, Kh. S. Arslanov, L.  G. Zhukova, I.  E. Khatkov
Publicado em 2022-01-01

Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved?

Por L G Zhukova, I P Ganshina, E I Khatkova, T E Tikhomirova, O E Kondratyeva
Publicado em 2018-06-01

Clinical features and results of surgical treatment of bilateral renal cancer

Por M. I. Komarov, V. B. Matveev, L. G. Zhukova, I. G. Komarov, V. A. Chernyaev
Publicado em 2018-03-01

Olaparib in the metastatic HER2-negative breast cancer setting

Por L. G. Zhukova, E. I. Khatkova, I. P. Ganshina, I. V. Kolyadina, E. V. Lubennikova
Publicado em 2020-12-01

Dermatomyositis and polymyositis in breast cancer patients: a case reports

Por I P Ganshina, L G Zhukova, E Z Burnevitch, O O Gordeeva, O E Kondratieva
Publicado em 2018-03-01

Role of palbociclib in the treatment of hormone receptor-positive HER2-negative metastatic breast cancer. Generalizing results of randomized trials and real clinical practice

Por L. G. Zhukova, E. I. Khatkova, P. S. Feoklistova, K. S. Grechukhina, S. A. Smolin, E. A. Arutyunyan, E. M. Kolyago
Publicado em 2019-06-01

Klinicheskaya effektivnost'i bezopasnost' primeneniya otechestvennogo rekombinantnogo granulotsitarnogo koloniestimuliruyushchego faktora Neypomaks® u bol'nykh rakom molochnoy zhel...

Por L G Zhukova, M E Abramov, Yu V Vakhabova, A N Lud, A A Obukhov, M R Lichinitser
Publicado em 2009-09-01

Pharmacogenetic testing of allelic variants of the CYP2D6 gene in hormone positive breast cancer

Por L. N. Lyubchenko, M. G. Filippova, T. A. Shendrikova, L. G. Zhukova, N. I. Mekhtieva, O. V. Krokhina, S. M. Portnoy
Publicado em 2017-10-01

The use of regorafenib in patients with disseminated gastrointestinal stromal tumours. A review of the literature. A clinical case

Por D. A. Filonenko, S. V. Petukhova, E. I. Khatkova, K. A. Vorontsova, E. I. Chichikov, B. M. Medvedeva, L. G. Zhukova
Publicado em 2018-07-01

Target therapy of luminal HER2-negative advanced breast cancer with PIK3CA mutation: combination of alpelisib plus fulvestrant in real clinical practice

Por D. A. Filonenko, T. M. Ibragimova, N. I. Polshina, A. V. Belogurova, E. I. Khatkova, E. A. Arutiunian, E. I. Volkova, L. G. Zhukova
Publicado em 2021-12-01

Hereditary breast cancer: genetic and clinical hetergeneity, genetic testing, prophylactic surgery

Por L. N. Lyubchenko, Ye. I. Bateneva, I. K. Vorotnikov, S. M. Portnoy, O. V. Krokhina, V. A. Sobolevskiy, L. G. Zhukova, V. A. Khaylenko, S. A. Tyulyandin
Publicado em 2015-06-01

THE MAIN PARAMETERS OF CELLULAR IMMUNITY IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER: RELATIONSHIP WITH EFFICIENCY OF CHEMOTHERAPY

Por A. I. Chertkova, E. G. Slavina, E. K. Shoua, L. G. Zhukova, M. A. Okruzhnova, V. A. Nurtdinova, A. A. Borunova, N. Т. Dzhgamadze, Z. G. Kadagidze
Publicado em 2018-11-01

METASTASIS OF RENAL CANCER TO BREAST: DESCRIPTION OF CLINICAL CASE

Por E. V. Chernova, V. A. Khaylenko, L. G. Zhukova, A. G. Abdullaev, D. V. Komov, L. N. Lyubchenko, A. V. Khaylenkо, N. E. Kudashkin, D. A. Burov
Publicado em 2018-09-01